Security record · archived quarter
NAGE
Niagen Bioscience Inc · Healthcare · Biotechnology
7Tracked holders
n/aΔ holders
2.06MShares held
$5.62MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 66 | -4 | 22.69M | $72.48M | +5 | −9 |
| Q1 2026 | 72 | -9 | 26.61M | $117.87M | +3 | −12 |
| Q4 2025 | 81 | 0 | 27.14M | $172.59M | +1 | −1 |
| Q3 2025 | 17 | +1 | 16.56M | $154.47M | +2 | −1 |
| Q2 2025 | 13 | -2 | 14.28M | $205.83M | n/a | −2 |
| Q1 2025 | 12 | +1 | 6.49M | $44.82M | +1 | n/a |
| Q4 2024 | 11 | +2 | 5.06M | $26.83M | +2 | n/a |
| Q3 2024 | 8 | +1 | 2.02M | $7.36M | +3 | −2 |
| Q2 2024 | 7 | n/a | 2.06M | $5.62M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.13M | n/a | $3.09M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Renaissance Technologies ✦ | 416.10K | n/a | $1.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | GAMCO Investors ✦ | 233.15K | n/a | $636,500 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 192.34K | n/a | $525,091 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 55.11K | n/a | $151,000 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 20.58K | n/a | $56,175 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 9.95K | n/a | $27,169 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 142 holders, 36.40M shares, $156.67M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API